# Table 3 Characteristics of index children living with HIV (N = 120) included in the quantitative component of the study

Variable Boys (N = 60) Girls (N = 60) p value Total (N = 120)
Age (years) 11.9 (2.9) 12.5 (3.5) 0.363* 12.2 (3.2)
Age at 1st diagnosis (years) 5.1 (3.8) 4.6 (3.5) 0.435* 4.9 (3.7)
Duration of ART treatment (years) 6.6 (3.4) 7.6 (4.2) 0.98* 7.0 (3.9)
Overall Age group: n (%)
School age 11 (18.8) 11 (18.3)   22 (18.3)
Early adolescence 25 (41.7) 33 (55.0)   58 (48.3)
Mid adolescence 15 (25.0) 11 (18.3)   26 (21.7)
Late adolescence 9 (15.0) 5 (8.3) 0.472** 14 (11.7)
School Attendance: n (%) 60 (100) 58 (96.7) 0.476** 118 (98.3)
On Antiretrovirals: n (%) 59 (98.3) 58 (96.7) 0.559** 117 (97.5)
Prevalence of disclosure: n (%) 18 (30.0) 25 (41.7) 0.253** 43 (35.8)
∫Disclosure rate by age-group: n (%)
School age 1 (9.1) 2 (18.2)   3 (13.6)
Early adolescence 3 (12.0) 10 (30.3)   13 (22.4)
Mid adolescence 6 (40.0) 8 (72.7)   14 (53.8)
Late adolescence 8 (88.9) 5 (100) 0.001** 13 (92.9)
Who made disclosure: N = 43 n (%)
Mother alone 7 (38.9) 8 (32.0)   15 (34.9)
Father alone 0 (0.0) 5 (20.0)   5 (11.6)
Health worker 4 (22.2) 9 (36.0)   13 (30.2)
Grandmother 2 (11.1) 1 (4.0)   3 (7.0)
Others 5 (27.8) 2 (8.0) 0.212** 7 (16.3)
1. Values presented as mean (SD), unless otherwise indicated, n (%) = Frequency (percentage), *Independent t-test p-values reported, **Chi-square p-values reported
2. Disclosure rate by age-group calculated based on overall number of children within each age group category (disclosed and non-disclosed)
3. ¶Others: mother and father combined, Sister, Brother, Neighbour, Step-mother, Guardian, and unknown person
4. School age (6–9 years), Early adolescence (10–13 years), Middle adolescence (14–16 years), Late adolescence (17–18 years) as described by Cromber et al. [17]